Kenvue Inc (KVUE): Multiplikator P/S
The price-to-sales ratio for Kenvue Inc. (KVUE) reflects the business valuation dynamics, where 2.40 describes the current status of the metric. The company's stability relies on global manufacturing plants and demand for essential consumer goods. Well-known brands and pharmacy chains create barriers to entry for newcomers under FDA supervision. A broad portfolio of hygiene products ensures ultra-reliable revenue diversification worldwide.
Kenvue Corp (KVUE) - rincian metrik lan laporan keuangan
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Kenvue Inc.|KVUE - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Kenvue Health|KVUE - Gunggung utang perusahaan|Utang-utang marang nilai buku Kenvue Corp|KVUE - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Kenvue|Koefisien jangkoan perantara kenvue.com
- data bathi lan kelipatan valuasi:
KVUE - Bathi resik perusahaan|Prakiraan bathi resik Kenvue Inc.|KVUE - Pangali P/E|Prakiraan rega marang bathi Kenvue Inc|KVUE - Pangali rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Kenvue Corp|KVUE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Kenvue|KVUE - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan kenvue.com|KVUE - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Kenvue Inc.
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:KVUE - kenvue.com
Steady demand for Kenvue Inc. (KVUE) over-the-counter drugs allows the company to index prices in line with inflation, making the market valuation based on sales volume a key indicator of business resilience. By analyzing the price-to-sales ratio, an investor determines how many market dollars are attributed to each unit of revenue, identifying phases of asset overvaluation or consolidation to optimize the entry point.
Karo sapa Kenvue Inc. saingan
HLN (haleon.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Verona Pharma VRNA|Multiplikator P/S Jyong Biotech Limited MENS|Ligand Pharma - Multiplikator P/S|Rega marang dodolan Amneal Corp|Perrigo Company plc (PRGO) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan ALVO|Kapitalisasi marang pendapatan LQDA|Rasio rega marang pendapatan GLPG|Kapitalisasi marang pendapatan ANIP (ANI Pharma)|Multiplikator P/S Afrezza (MNKD)|Multiplikator P/S AMPH (Amphastar Pharmaceuticals)|pacira.com (PCRX) - Rega marang dodolan|SPRY: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan TBPH (Theravance Biopharma Inc)|AQST: Multiplikator P/S|SCPH - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Tectonic Therapeutic Inc.|Rasio kapitalisasi marang pendapatan TNXP (tonixpharma.com)|Multiplikator P/S SXTC|Kapitalisasi marang pendapatan eupraxiapharma.com EPRX|BioHarvest - Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Invizyne (EXOZ)|ORMP - Rasio rega marang pendapatan|ENTX - Multiplikator P/S|HYFT (MindWalk Holdings Inc.) - Kapitalisasi marang pendapatan|ABVC (ABVC BioPharma Inc.) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan CPIX|Multiplikator P/S Quantum BioPharma Corp|Multiplikator P/S FGEN|TELO - Rega marang dodolan|Rasio rega marang pendapatan Rani Therapeutics Holdings, Inc. RANI|SNYR (Synergy CHC Corp.) - Rasio rega marang dodolan|Rallybio Corp. - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan LEXX (Lexaria Bioscience)|PULM: Multiplikator P/S|Pheton Holdings (PTHL) - Multiplikator P/S|Rasio rega marang pendapatan Aptorum Group Ltd|LYRA: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Impact BioMedical (IBO)|Kapitalisasi marang pendapatan tnfpharma.com TNFA|Multiplikator P/S YCBD (cbdMD)|Multiplikator P/S painreform.com PRFX|CYTO: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan LIPO (Lipella Pharmaceuticals Inc)|Optinose (OPTN) - Rasio rega marang pendapatan|Rega marang dodolan Pieris Pharma (PIRS)|Kapitalisasi marang pendapatan PROC|PTPI (petrospharma.com) - Kapitalisasi marang volume dodolan|Multiplikator P/S QLI|SLRN (Acelyrin Inc.) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S TFFP (TFF Pharma)
